Jeffrey A Meyerhardt Selected Research

Cyclooxygenase 2 (Cyclooxygenase-2)

1/2021	Effect of Celecoxib vs Placebo Added to Standard Adjuvant Therapy on Disease-Free Survival Among Patients With Stage III Colon Cancer: The CALGB/SWOG 80702 (Alliance) Randomized Clinical Trial.
1/2020	An integrated analysis of lymphocytic reaction, tumour molecular characteristics and patient survival in colorectal cancer.
1/2019	Prognostic association of PTGS2 (COX-2) over-expression according to BRAF mutation status in colorectal cancer: Results from two prospective cohorts and CALGB 89803 (Alliance) trial.
11/2018	Vitamin D status after colorectal cancer diagnosis and patient survival according to immune response to tumour.
10/2018	Physical Activity and Colorectal Cancer Prognosis According to Tumor-Infiltrating T Cells.
1/2018	Marine ω-3 Polyunsaturated Fatty Acid and Fish Intake after Colon Cancer Diagnosis and Survival: CALGB 89803 (Alliance).
12/2017	Tumor expression of calcium sensing receptor and colorectal cancer survival: Results from the nurses' health study and health professionals follow-up study.
6/2017	Aspirin Use and Colorectal Cancer Survival According to Tumor CD274 (Programmed Cell Death 1 Ligand 1) Expression Status.
1/2016	MicroRNA MIR21 (miR-21) and PTGS2 Expression in Colorectal Cancer and Patient Survival.
1/2016	Neoadjuvant irinotecan, cisplatin, and concurrent radiation therapy with celecoxib for patients with locally advanced esophageal cancer.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jeffrey A Meyerhardt Research Topics

Disease

133	Colorectal Neoplasms (Colorectal Cancer) 10/2022 - 04/2004
124	Neoplasms (Cancer) 11/2022 - 01/2004
66	Colonic Neoplasms (Colon Cancer) 10/2022 - 02/2003
36	Microsatellite Instability 10/2022 - 01/2006
12	Carcinogenesis 04/2022 - 12/2006
11	Carcinoma (Carcinomatosis) 01/2019 - 08/2003
10	Adenocarcinoma 01/2022 - 02/2007
8	Rectal Neoplasms (Rectal Cancer) 01/2022 - 01/2004
8	Hepatocellular Carcinoma (Hepatoma) 10/2021 - 08/2007
7	Adenoma (Adenomas) 04/2022 - 08/2005
7	Disease Progression 01/2022 - 12/2008
7	Insulin Resistance 12/2020 - 09/2013
6	Obesity 01/2020 - 08/2003
5	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2022 - 08/2006
5	Leukemia 01/2022 - 09/2008
5	Inflammation (Inflammations) 12/2020 - 09/2015
5	Neutropenia 01/2019 - 04/2004
4	Polyps 04/2022 - 01/2020
4	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 08/2005
4	Hyperinsulinism (Hyperinsulinemia) 08/2020 - 09/2017
4	Pancreatic Neoplasms (Pancreatic Cancer) 01/2018 - 10/2007
4	Carcinoid Tumor (Carcinoid) 08/2012 - 08/2006
4	Diarrhea 01/2012 - 04/2006
3	Peripheral Nervous System Diseases (PNS Diseases) 10/2022 - 01/2010
3	Esophageal Neoplasms (Esophageal Cancer) 01/2021 - 01/2013
3	Hypertension (High Blood Pressure) 01/2021 - 01/2010
3	Type 2 Diabetes Mellitus (MODY) 12/2020 - 11/2015
3	Breast Neoplasms (Breast Cancer) 02/2020 - 04/2011
3	Lymphopenia (Lymphocytopenia) 06/2014 - 11/2011
3	Stomach Neoplasms (Stomach Cancer) 05/2007 - 04/2002

Drug/Important Bio-Agent (IBA)

35	Biomarkers (Surrogate Marker)IBA 01/2022 - 06/2005
23	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2021 - 01/2006
20	Fluorouracil (Carac)FDA LinkGeneric 10/2022 - 04/2002
19	Oxaliplatin (Eloxatin)FDA LinkGeneric 10/2022 - 04/2006
17	Irinotecan (Camptosar)FDA LinkGeneric 01/2022 - 04/2004
16	Leucovorin (Folinic Acid)FDA Link 10/2022 - 09/2005
15	NucleotidesIBA 04/2021 - 06/2009
13	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 03/2021 - 08/2005
13	Insulin (Novolin)FDA Link 01/2020 - 12/2008
12	Bevacizumab (Avastin)FDA Link 01/2022 - 05/2007
12	Cetuximab (Erbitux)FDA Link 01/2022 - 05/2006
12	Vitamin D FDA LinkGeneric 01/2021 - 06/2008
10	DNA (Deoxyribonucleic Acid)IBA 10/2022 - 01/2006
9	Fatty Acid Synthases (Fatty Acid Synthase)IBA 03/2012 - 01/2006
8	hydroxide ionIBA 11/2020 - 06/2008
8	ErbB Receptors (EGF Receptor)IBA 01/2012 - 12/2004
7	Biological ProductsIBA 11/2022 - 04/2002
7	25-hydroxyvitamin DIBA 01/2021 - 06/2008
7	beta CateninIBA 10/2018 - 07/2007
7	Insulin-Like PeptidesIBA 03/2016 - 06/2005
6	CalciumIBA 01/2020 - 01/2018
5	Coffee FDA Link 01/2022 - 11/2015
5	Proteins (Proteins, Gene)FDA Link 01/2021 - 06/2005
5	Cisplatin (Platino)FDA LinkGeneric 01/2016 - 04/2002
5	ElementsIBA 11/2015 - 04/2011
5	Tyrosine Kinase InhibitorsIBA 03/2013 - 09/2005
5	Cyclin D1IBA 03/2011 - 06/2009
5	Gemcitabine FDA Link 01/2010 - 02/2007
4	Capecitabine (Xeloda)FDA Link 10/2022 - 04/2006
4	Everolimus FDA Link 01/2022 - 01/2009
4	AdiponectinIBA 01/2021 - 09/2013
4	C-PeptideIBA 08/2020 - 06/2005
4	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2019 - 10/2017
4	Insulin-Like Growth Factor I (IGF-1)IBA 09/2013 - 06/2005
4	CateninsIBA 06/2013 - 03/2011
4	Gefitinib (Iressa)FDA Link 10/2007 - 09/2005
3	SugarsIBA 01/2022 - 01/2021
3	FructoseIBA 01/2022 - 11/2012
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022 - 08/2012
3	Cholecalciferol (Vitamin D3)FDA Link 01/2021 - 01/2019
3	Insulin-Like Growth Factor Binding ProteinsIBA 01/2021 - 01/2009
3	Branched-Chain Amino AcidsIBA 12/2020 - 01/2020
3	ParaffinIBA 01/2020 - 09/2005
3	Calcifediol (Calcidiol)FDA Link 07/2019 - 06/2008
3	Dietary Fiber FDA Link 06/2019 - 07/2017
3	Dinoprostone (PGE2)FDA Link 01/2019 - 01/2016
3	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 01/2018 - 09/2015
3	LigandsIBA 01/2018 - 08/2007
3	Tumor Biomarkers (Tumor Markers)IBA 12/2017 - 09/2012
3	Monoclonal AntibodiesIBA 01/2017 - 01/2012
3	Calcibiotic Root Canal SealerIBA 04/2016 - 09/2014
3	Alanine Transaminase (SGPT)IBA 06/2014 - 01/2010
3	Phosphotransferases (Kinase)IBA 12/2013 - 11/2011
3	Phosphatidylinositols (Phosphatidylinositol)IBA 12/2013 - 09/2009
3	Temozolomide (Temodar)FDA LinkGeneric 08/2012 - 10/2008
3	Cyclin-Dependent Kinases (cdk Proteins)IBA 03/2011 - 07/2009
3	TabletsIBA 10/2010 - 08/2005
3	MethyltransferasesIBA 01/2009 - 01/2006

Therapy/Procedure

49	Therapeutics 10/2022 - 04/2002
49	Drug Therapy (Chemotherapy) 10/2022 - 04/2002
35	Adjuvant Chemotherapy 10/2022 - 02/2003
6	Radiotherapy 01/2022 - 02/2004
5	Aftercare (After-Treatment) 05/2022 - 05/2006
4	Neoadjuvant Therapy 01/2022 - 05/2007
4	Immunotherapy 01/2021 - 11/2016
4	Combination Drug Therapy (Combination Chemotherapy) 02/2012 - 06/2005
3	Length of Stay 01/2022 - 05/2013
3	Chemoprevention 01/2021 - 08/2005
3	Drug Tapering 01/2021 - 09/2006
3	Biological Therapy 12/2019 - 02/2014